Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T‐cell lymphoma

Peripheral T‐cell lymphoma (PTCL) is a heterogeneous group of aggressive non‐Hodgkin lymphomas typically associated with poor prognosis. Most patients with PTCL receive chemotherapy as first‐line treatment, but many experience rapid relapse. For patients with relapsed/refractory PTCL, responses to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Foss, Francine, Pro, Barbara, Miles Prince, H., Sokol, Lubomir, Caballero, Dolores, Horwitz, Steven, Coiffier, Bertrand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269566/
https://www.ncbi.nlm.nih.gov/pubmed/27981793
http://dx.doi.org/10.1002/cam4.939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269566/
https://www.ncbi.nlm.nih.gov/pubmed/27981793
http://dx.doi.org/10.1002/cam4.939

Ejemplares similares